Global Cardiology Academy

Welcome to Global
Cardiology Academy

Enhance your cardiology practice with CME and
tools focused on heart health management.

Setting the Stage of Real-World Data vs RCT
Setting the Stage of Real-World Data vs RCT
MinuteCE®
Setting the Stage of Real-World Data vs RCT
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
1.00 program credit
Don't Miss It! Rapid & Accurate AAV Diagnosis 
Don't Miss It! Rapid & Accurate AAV Diagnosis 
MinuteCE®
Don't Miss It! Rapid & Accurate AAV Diagnosis 
0.75 program credits
- Silke R. Brix, MD, MRCP, SCPR
- Andreas Kronbichler, MD
0.75 program credits
MinuteCE®
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
0.75 credits 6 episodes
- Bernhard Hellmich, MD
- Andreas Kronbichler, MD
- Silke R. Brix, MD, MRCP, SCPR
0.75 credits 6 episodes
Elevating Care for Patients With Severe Renal Disease in AAV
Elevating Care for Patients With Severe Renal Disease in AAV
MinuteCE®
Elevating Care for Patients With Severe Renal Disease in AAV
0.75 program credits
- Silke R. Brix, MD, MRCP, SCPR
- Andreas Kronbichler, MD
0.75 program credits
Patient Case Study: Elderly
Patient Case Study: Elderly
MinuteCE®
Patient Case Study: Elderly
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
Patient Case Study: Obesity and VTE
Patient Case Study: Obesity and VTE
MinuteCE®
Patient Case Study: Obesity and VTE
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Alexander T. Cohen, MD, MBBS
1.00 program credit
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
MinuteCE®
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
1.00 program credit
- Alexander T. Cohen, MD, MBBS
1.00 program credit
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
MinuteCE®
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
1.00 program credit
- Alexander T. Cohen, MD, MBBS
1.00 program credit

Programs

Optimizing AAV Outcomes: Maintenance Therapies
Optimizing AAV Outcomes: Maintenance Therapies
MinuteCE®
Optimizing AAV Outcomes: Maintenance Therapies
0.75 program credits
- Bernhard Hellmich, MD
- Silke R. Brix, MD, MRCP, SCPR
0.75 program credits
Implementing the SOC Induction Therapies in AAV 
Implementing the SOC Induction Therapies in AAV 
MinuteCE®
Implementing the SOC Induction Therapies in AAV 
0.75 program credits
- Silke R. Brix, MD, MRCP, SCPR
- Bernhard Hellmich, MD
0.75 program credits
Managing Patients With AAV in the Rheumatology Clinic
Managing Patients With AAV in the Rheumatology Clinic
MinuteCE®
Managing Patients With AAV in the Rheumatology Clinic
0.75 program credits
- Andreas Kronbichler, MD
- Bernhard Hellmich, MD
0.75 program credits
Patient Case Study: Obesity
Patient Case Study: Obesity
MinuteCE®
Patient Case Study: Obesity
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
MinuteCE®
AF and VTE: Global Considerations in the Evolving Space of Real-World Data
1.00 credit 10 episodes
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
- Alexander T. Cohen, MD, MBBS
1.00 credit 10 episodes
Patient Case Study: Cancer-Associated Thrombosis
Patient Case Study: Cancer-Associated Thrombosis
MinuteCE®
Patient Case Study: Cancer-Associated Thrombosis
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Alexander T. Cohen, MD, MBBS
1.00 program credit
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
CME/CE
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
0.25 credits
- Kieran McCafferty, MD
- Maurizio Gallieni, MD
0.25 credits
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
CME/CE
AHA 2024 and Acoramidis: Impact on the Future of ATTR-CM Patient Care
- Mazen Hanna, MD

Clinical Practice

Trade off: Ischemic/Thrombotic vs Bleeding  
Trade off: Ischemic/Thrombotic vs Bleeding  
MinuteCE®
Trade off: Ischemic/Thrombotic vs Bleeding  
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
1.00 program credit
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
MinuteCE®
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
1.00 program credit
- Valeria Caso, MD, PhD
1.00 program credit
LDL-C Management Trends in ASCVD Patients
LDL-C Management Trends in ASCVD Patients
Heart Matters
LDL-C Management Trends in ASCVD Patients
- Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
CME/CE
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
0.50 credits
- John Russell, MD
- Noel Dasgupta, MD, FACC
- Sami Khella, MD
0.50 credits
Bempedoic acid reduces adverse limb events in patients with PAD
Bempedoic acid reduces adverse limb events in patients with PAD
Heart Matters
Bempedoic acid reduces adverse limb events in patients with PAD
- Marc Bonaca, MD
No benefit of routine spironolactone post-MI
No benefit of routine spironolactone post-MI
Heart Matters
No benefit of routine spironolactone post-MI
- Sanjit Jolly, MD
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
Heart Matters
Semaglutide reduces MACE in patients with obesity or overweight and prior CABG
- Subodh Verma, MD, PhD
Tirzepatide reduces HF events in patients with HFpEF and obesity
Tirzepatide reduces HF events in patients with HFpEF and obesity
Heart Matters
Tirzepatide reduces HF events in patients with HFpEF and obesity
- Milton Packer, MD

CME

Tailoring Treatment for Optimal Outcomes in Patients With AAV
Tailoring Treatment for Optimal Outcomes in Patients With AAV
MinuteCE®
Tailoring Treatment for Optimal Outcomes in Patients With AAV
0.75 program credits
- Bernhard Hellmich, MD
- Andreas Kronbichler, MD
0.75 program credits
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
CME/CE
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
0.50 credits
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
- Scott Solomon, MD
- Mikhail Kosiborod, MD
0.50 credits
MinuteCE®
Optimizing Heart Failure Management
0.75 credits 5 episodes
- Brian P. McDonough, MD, FAAFP
- Barry Greenberg, MD
- Neil Skolnik, MD
- Trina Huynh, PharmD
- Jessica Lin, MPAP
- Melissa Mclenon, DNP, ACNP-BC
- Karina Brown, BSN, RN
0.75 credits 5 episodes
Level Up Your Skills: Tailoring Management of HF
Level Up Your Skills: Tailoring Management of HF
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 program credits
- Neil Skolnik, MD
- Barry Greenberg, MD
- Trina Huynh, PharmD
- Jessica Lin, MPAP
- Melissa Mclenon, DNP, ACNP-BC
- Karina Brown, BSN, RN
0.75 program credits
HF Management for Patients with Comorbid Conditions
HF Management for Patients with Comorbid Conditions
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 program credits
- Neil Skolnik, MD
- Barry Greenberg, MD
- Karina Brown, BSN, RN
- Jessica Lin, MPAP
- Melissa Mclenon, DNP, ACNP-BC
0.75 program credits
Right from the Onset: DVT Diagnosis, Management
Right from the Onset: DVT Diagnosis, Management
MinuteCE®
Right from the Onset: DVT Diagnosis, Management
1.75 program credits
- Bruce L. Davidson, MD, MPH
1.75 program credits
MinuteCE®
Primary Prevention, Initial Treatment & Management of VTE, Secondary VTE Prevention Strategies
1.75 credits 12 episodes
- Bruce L. Davidson, MD, MPH
- Scott Kaatz, DO, MSc, FACP, SFHM
- Deborah Siegal, MD, MSc, FRCPC
- Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
- Alfonso J. Tafur, MD, MS, MBA, RPVI
- Victor F. Tapson, MD
1.75 credits 12 episodes
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
MinuteCE®
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
1.75 program credits
- Alex C. Spyropoulos, MD, FACP, FCCP, FRCPC
1.75 program credits